Riddhi Siddhi Gluco Biols Ltd

Riddhi Siddhi Gluco Biols Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Feb 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 16 February 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Riddhi Siddhi Gluco Biols Ltd., a micro-cap trading and distribution company with a market capitalisation of ₹377.00 crores, reported deeply concerning Q3 FY26 results that highlight persistent operational challenges. The company posted a consolidated net loss of ₹1.59 crores for the quarter ended December 2025, representing a sharp 111.74% decline quarter-on-quarter and a 95.59% plunge year-on-year. The stock, trading at ₹530.00 as of February 06, 2026, has declined 8.67% over the past year, significantly underperforming the Sensex's 7.07% gain during the same period.

Riddhi Siddhi Gluco Biols Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 February 2025, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 05 February 2026, providing investors with the latest comprehensive view of the company’s position.

Riddhi Siddhi Gluco Biols Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 Feb 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 25 January 2026, providing investors with the most recent insights into its performance and outlook.

Riddhi Siddhi Gluco Biols Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 February 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 14 January 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Riddhi Siddhi Gluco Biols Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 February 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 03 January 2026, providing investors with the latest insights into its performance and outlook.

Riddhi Siddhi Gluco Biols Ltd’s stock declined to a fresh 52-week low of Rs.405 today, marking a significant milestone in its ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting persistent pressures on its financial performance and valuation metrics.

Riddhi Siddhi Gluco Biols Ltd’s stock touched a fresh 52-week low of Rs.433.25 today, marking a significant downturn as the share price continues to slide amid persistent negative financial trends and underperformance relative to the broader market and sector indices.

Riddhi Siddhi Gluco Biols Ltd’s shares declined to a fresh 52-week low of Rs.441.2 on 29 Dec 2025, marking a significant downturn amid a series of quarterly setbacks and subdued financial metrics. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures within the Trading & Distributors industry.

Riddhi Siddhi Gl, a microcap player in the Trading & Distributors sector, has experienced a notable revision in its market evaluation metrics, reflecting ongoing challenges in its financial and operational performance. This shift highlights the company’s current standing amid a difficult market environment and persistent negative trends across key financial parameters.

Riddhi Siddhi Gluco Biols touched a fresh 52-week low of Rs.448 today, marking a significant decline amid a sustained downward trend. The stock has recorded losses over the past three consecutive sessions, reflecting ongoing pressures within the Trading & Distributors sector.

Riddhi Siddhi Gluco Biols touched a fresh 52-week low of Rs.451.2 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial performance and market valuation.

Riddhi Siddhi Gluco Biols has reached a new 52-week low of Rs.451.6 today, marking a significant decline amid ongoing downward momentum. The stock has experienced notable volatility and underperformance relative to its sector and broader market indices.

Riddhi Siddhi Gl, a microcap player in the Trading & Distributors sector, has experienced a notable revision in its market evaluation, reflecting ongoing challenges in its financial and operational metrics. This shift highlights concerns across multiple analytical parameters, underscoring the company’s current position within a competitive and volatile market environment.

Riddhi Siddhi Gluco Biols Ltd., a micro-cap trading and distribution company with a market capitalisation of ₹390.00 crores, posted a consolidated net profit of ₹13.54 crores for Q2 FY26, representing a remarkable 63.53% quarter-on-quarter increase. However, this headline figure conceals a deeply troubling operational reality: net sales collapsed by 79.24% QoQ to just ₹32.10 crores, whilst the company's profitability became almost entirely dependent on non-operating income of ₹22.13 crores—representing a staggering 134.21% of profit before tax.